Journals / Fırat Tıp Dergisi / 2013 / Cilt: 18 - Sayı: 2

The importance of thrombophilic factors in early pregnancy losses

Erken gebelik kayıplarında trombofilik faktörlerin önemi

Pages
88–93
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: High prevelance of of thrombophilia found in patients with fetal loss at >10 gestational weeks suggests that thrombophilia screening should be a part of the management of these patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of the present study was to investigate the role of thrombophilic factors in fetal losses at 10-16 gestational weeks.
📊
Key Findings & Data:Materials and Methods: Between April 2003 and May 2004, 50 women who were hospitalized due to fetal loss at 10-16 gestational weeks were defined as study group and 50 women with at least 1 healthy term infant and had no previous miscarriage history were defined as control group.
💡
Conclusion & Impact:Conclusion: High prevelance of of thrombophilia found in patients with fetal loss at >10 gestational weeks suggests that thrombophilia screening should be a part of the management of these patients.
🔬Design:Research Article
📍Scope:2003 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: The aim of the present study was to investigate the role of thrombophilic factors in fetal losses at 10-16 gestational weeks. Materials and Methods: Between April 2003 and May 2004, 50 women who were hospitalized due to fetal loss at 10-16 gestational weeks were defined as study group and 50 women with at least 1 healthy term infant and had no previous miscarriage history were defined as control group. Activated protein C resistance, anti-thrombin III deficiency, protein S deficiency and the presence of anticardiolipin antibodies were evaluated. Chi- square test and independent sample t-test were used for statistical analysis. The cut-off value for statistical significance was set at p <0.05. Results: The groups were similar with regard to mean serum antithrombin III, anticardiolipin antibodies and protein S level. However, activated protein C resistance was more frequent in the study group (22% vs 6%, p=0,047). Moreover, thrombophilia prevelance was higher in study group when compared to control group (42% vs 16%, p=0.001). Conclusion: High prevelance of of thrombophilia found in patients with fetal loss at >10 gestational weeks suggests that thrombophilia screening should be a part of the management of these patients.

Özet

Amaç: 10-16 gebelik haftası arası meydana gelen fetal kayıplarda kalıtımsal ve kazanılmış trombofilik faktörlerin rolünün incelenmesi. Gereç ve Yöntem: Nisan 2003-Mayıs 2004 tarihleri arasında 10-16 gebelik haftasında fetal kayıp nedeniyle Ankara Etlik Zübeyde Hanım Doğumevi Erken Gebelik Servisine yatırılan 50 hasta çalışma grubu olarak, daha önce gebelik kaybı öyküsü olmayan ve en az bir sağlıklı doğum yapmış 50 kadın kontrol grubu olarak kabul edildi. Tüm hastalarda aktive protein C resistansı, protein S ve antitrombin 3 eksikliği ve antikardiyolipin antikor pozitifliği araştırıldı. Her iki grup arasında bu parametreler açısından fark olup olmadığı bağımsız T testi, ki-kare testi kullanılarak incelendi. P<0,05 istatistiksel olarak anlamlı kabul edildi. Bulgular: Çalışma ve kontrol grubundaki hastaların ortalama serum antitrombin III, antikardiyolipin antikor ve protein S düzeyleri istatistiksel olarak benzer bulundu. Ancak, aktive protein C rezistansı pozitifliği çalışma grubunda anlamlı olarak yüksek bulundu (22% vs 6%, p=0,047). Ayrıca, trom- bofili prevelansı kontrol grubuna kıyasla çalışma grubunda istatistiksel olarak daha yüksek saptandı (%42 vs %16, p=0.001). Sonuç: Sonuç olarak 10. Gebelik haftası sonrası meydana gelen gebelik kayıplarında trombofili prevelansı yüksek olup bu dönemde meydana gelen gebelik kayıplarında araştırılmalıdır.

🔖

Cite This Article

ŞEN, S., HIZLI, D., TAŞCI, Y., DİLBAZ, S. (2013). The importance of thrombophilic factors in early pregnancy losses. Fırat Tıp Dergisi, Cilt: 18 - Sayı: 2, 88–93. https://ajindex.com/articles/214167

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Kupferminc MJ. Thrombophilia and pregnancy. Reprod Biol Endoc 2003; 1: 111. Jordaan DJ, Schoon MG, Badenhorst PN. Thrombophilia screening in pregnancy. Obstet Gynecol Surv 2005; 60: 394- 404. Preston FE, Rosendaal FR, Walker ID, et al. Increased fetal loss in women with heritable thrombophilia. Lancet 1996; 348: 913-6. de Vries JI, Dekker GA, Huijgens PC, Jakobs C, Blomberg BM, van Geijn HP. Hyperhomocysteinaemia and protein S de- ficiency in complicated pregnancies. Br J Obstet Gynaecol 1997; 104: 1248-54. van der Molen EF, Verbruggen B, Nováková I, Eskes TK, Monnens LA, Blom HJ. Hyperhomocysteinemia and other thrombotic risk factors in women with placental vasculopathy. BJOG 2000; 107: 785-91.
  2. Martinelli I, Taioli E, Cetin I, et al. Mutations in coagulation factors in women with unexplained late fetal loss. N Engl J Med 2000; 343: 1015-8.
  3. Many A, Elad R, Yaron Y, Eldor A, Lessing JB, Kupferminc MJ. Third-trimester unexplained intrauterine fetal death is as- sociated with inherited thrombophilia. Obstet Gynecol 2002; 99: 684-7.
  4. Kupferminc MJ, Fait G, Many A, Gordon D, Eldor A, Lessing JB. Severe preeclampsia and high frequency of genetic throm- bophilic mutations. Obstet Gynecol 2000; 96: 45-9. Brown HL. Antiphospholipid antibodies and recurrent preg- nancy loss. Clin Obstet Gynecol 1991; 34: 1-17.
  5. Tal J, Schliamser LM, Leibovitz Z, Ohel G, Attias D. A possible role for activated protein C resistance in patients with first and second trimester pregnancy failure. Hum Reprod 1999; 14: 1624-7.
  6. Rai R, Shlebak A, Cohen H, et al. Factor V Leiden and acqui- red activated protein C resistance among 1000 women with re- current miscarriage. Hum Reprod 2001; 16: 961-5. Roqué H, Paidas MJ, Funai EF, Kuczynski E, Lockwood CJ. Maternal thrombophilias are not associated with early preg- nancy loss. Thromb Haemost 2004; 91: 290-5.
  7. Burton GJ, Jauniaux E, Watson AL. Maternal arterial connec- tions to the placental intervillous space during the first trimes- ter of human pregnancy: the Boyd collection revisited. Am J Obstet Gynecol 1999; 181: 718-24.
  8. Oshiro BT, Silver RM, Scott JR, Yu H, Branch DW.Antiphospholipid antibodies and fetal death. Obstet Gy- necol 1996; 87: 489-93.
  9. Alonso A, Soto I, Urgellés MF, Corte JR, Rodríguez MJ, Pinto CR. Acquired and inherited thrombophilia in women with unexplained fetal losses. Am J Obstet Gynecol 2002; 187: 1337-42.
  10. Mello G, Parretti E, Martini E, et al. Usefulness of screening for congenital or acquired hemostatic abnormalities in wom